Titan America SA, the US unit of Titan Cement International SA, has filed for an initial public offering in New York, showing ...

Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a U.S.

A successful micro-cap IPO relies on telling a compelling growth story, backed by consistent financial data. Ensure that your ...

Antharas said it expects the IPO to price between $4 and $5 per share. The company applied to list on the Nasdaq Capital Market under the symbol AAS. For the year ended Dec. 31, 2023, the company ...

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Gold jewellery maker Shanti Gold International has filed preliminary papers with SEBI to raise funds via initial public ...

Venture Global is seeking up to $110.38 billion valuation in its New York initial public offering, the second-largest U.S.

Metsera (MTSR), which is developing ultra-long-acting drugs for obesity, has filed for a $100M initial public offering. Read more here.

The EV maker expects a spurt of 80% in value from previous funding. Zerodha cofounder Nikhil Kamath, an investor in the ...

Venture Global Inc. is seeking to raise $2.3 billion in what would be the largest US initial public offering by an energy ...

Fintech giant Groww is reportedly gearing up to file for an initial public offering (IPO) in the next 10-12 months ...

The IPO, with an equity share face value of ₹10, consists entirely of a fresh issuance of up to 18 million equity shares.